ArticleInvestigational new drugs2026

Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.

Wenjun Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.